|
抗肺炎球菌血清型14单克隆抗体[克隆13-111A]21/288
|
EA
|
21/288
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型10A单克隆抗体[克隆17-117IA3IIB6]21/284
|
EA
|
21/284
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型8单克隆抗体[克隆7D3]21/278
|
EA
|
21/278
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型12F单克隆抗体[克隆1C1]21/286
|
EA
|
21/286
|
2883
|
1-4/12周
|
|
第1批国际标准2022抗β2GPI-IgG-200IU/瓶21/266
|
EA
|
21/266
|
4988
|
1-4/12周
|
|
抗肺炎球菌血清型6A/6C单克隆抗体[克隆14-107JG10IA1/IB1IIG10]21/274
|
EA
|
21/274
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型3单克隆抗体[克隆15-103FC11IH5]21/270
|
EA
|
21/270
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型5单克隆抗体[克隆1366LC1IE11]21/272
|
EA
|
21/272
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型7F单克隆抗体[克隆15-102HG6ID8]21/276
|
EA
|
21/276
|
2883
|
1-4/12周
|
|
抗肺炎球菌血清型1单克隆抗体[clone13-110A21/268
|
EA
|
21/268
|
2883
|
1-4/12周
|
|
流感病毒传染性B/密歇根/1/2021[B/维多利亚谱系]21/244
|
EA
|
21/244
|
咨询
|
1-4/12周
|
|
甲型流感病毒/广东茂南/SWL/1536/2019[H1N1]21/238
|
EA
|
21/238
|
咨询
|
1-4/12周
|
|
流感病毒传染性BVR-27[B-维多利亚谱系]4658021/248
|
EA
|
21/248
|
咨询
|
1-4/12周
|
|
流感病毒传染性CNIC-1909[H1N1]21/240
|
EA
|
21/240
|
咨询
|
1-4/12周
|
|
传染性B型流感病毒/新加坡/WUH4618/2021[B-维多利亚谱系]21/242
|
EA
|
21/242
|
咨询
|
1-4/12周
|
|
流感病毒传染性IVR-228[H3N2]21/246
|
EA
|
21/246
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/达尔文/6/2021[H3N2]21/212
|
EA
|
21/212
|
咨询
|
1-4/12周
|
|
流感病毒传染性BVR-25[B-维多利亚谱系]21/216
|
EA
|
21/216
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/达尔文/9/2021[H3N2]21/214
|
EA
|
21/214
|
咨询
|
1-4/12周
|
|
流感病毒传染性NIB-127[H3N2]21/226
|
EA
|
21/226
|
咨询
|
1-4/12周
|